Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Sage Therapeutics, Inc. | sage-ex321_7.htm |
| EX-31.2 - EX-31.2 - Sage Therapeutics, Inc. | sage-ex312_6.htm |
| EX-31.1 - EX-31.1 - Sage Therapeutics, Inc. | sage-ex311_9.htm |
| EX-21.1 - EX-21.1 - Sage Therapeutics, Inc. | sage-ex211_10.htm |
| EX-10.32 - EX-10.32 - Sage Therapeutics, Inc. | sage-ex1032_1048.htm |
| 10-K - 10-K - Sage Therapeutics, Inc. | sage-10k_20161231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (File Nos. 333-208870) and on Form S-8 (File Nos. 333-197498, 333-204549, 333-209831 and 333-216202) of Sage Therapeutics, Inc. of our report dated February 24, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, MA
February 24, 2017